Associations of cholecystectomy with the risk of colorectal cancer: a Mendelian randomization study

被引:1
|
作者
Chen Lanlan [1 ]
Fan Zhongqi [1 ]
Sun Xiaodong [1 ]
Qiu Wei [1 ]
Mu Wentao [1 ]
Chai Kaiyuan [1 ]
Cao Yannan [1 ]
Wang Guangyi [1 ]
Lv Guoyue [1 ]
机构
[1] Department of Hepatobiliary and Pancreatic Surgery
[2] General Surgery Center  3. First Hospital of Jilin University  4. Changchun  5. Jilin 13
基金
中国国家自然科学基金;
关键词
Cholelithiasis; Irritable bowel syndrome; Inflammatory bowel disease; Causal inference; Colorectal cancer; Cholecystectomy; Mendelian randomization;
D O I
暂无
中图分类号
R735.34 [];
学科分类号
100214 ;
摘要
Background: Cholecystectomy is a standard surgery for patients suffering from gallbladder diseases, while the causal effects of cholecystectomy on colorectal cancer (CRC) and other complications are still unknown.Methods: We obtained genetic variants associated with cholecystectomy at a genome-wide significant level (P value <5 × 10-8) as instrumental variables (IVs) and performed Mendelian randomization (MR) to identify the complications of cholecystectomy. Furthermore, the cholelithiasis was also treated as the exposure to compare its causal effects to those of cholecystectomy, and multivariable MR analysis was carried out to judge whether the effect of cholecystectomy was independent of cholelithiasis. The study was reported based on Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization guidelines.Results: The selected IVs explained 1.76% variance of cholecystectomy. Our MR analysis suggested that cholecystectomy cannot elevate the risk of CRC (odds ratio [OR] =1.543, 95% confidence interval [CI]: 0.607–3.924). Also, it was not significant in either colon or rectum cancer. Intriguingly, cholecystectomy might decrease the risk of Crohn’s disease (OR = 0.078, 95% CI: 0.016-0.368) and coronary heart disease (OR = 0.352, 95% CI: 0.164–0.756). However, it might increase the risk of irritable bowel syndrome (IBS) (OR = 7.573, 95% CI: 1.096–52.318). Cholelithiasis could increase the risk of CRC in the largest population (OR = 1.041, 95% CI: 1.010–1.073). The multivariable MR analysis suggested that genetic liability to cholelithiasis could increase the risk of CRC in the largest population (OR = 1.061, 95% CI: 1.002–1.125) after adjustment of cholecystectomy.Conclusions: The study indicated that cholecystectomy might not increase the risk of CRC, but such a conclusion needs further proving by clinical equivalence. Additionally, it might increase the risk of IBS, which should be paid attention to in clinical practice.
引用
收藏
相关论文
共 50 条
  • [21] Associations between diet and incidence risk of lung cancer: A Mendelian randomization study
    Yan, Haihao
    Jin, Xiao
    Zhang, Changwen
    Zhu, Changjun
    He, Yucong
    Du, Xingran
    Feng, Ganzhu
    FRONTIERS IN NUTRITION, 2023, 10
  • [22] Associations Between Glycemic Traits and Colorectal Cancer: A Mendelian Randomization Analysis
    Murphy, Neil
    Song, Mingyang
    Papadimitriou, Nikos
    Carreras-Torres, Robert
    Langenberg, Claudia
    Martin, Richard M.
    Tsilidis, Konstantinos K.
    Barroso, Ines
    Chen, Ji
    Frayling, Tim
    Bull, Caroline J.
    Vincent, Emma E.
    Cotterchio, Michelle
    Gruber, Stephen B.
    Pai, Rish K.
    Newcomb, Polly A.
    Perez-Cornago, Aurora
    van Duijnhoven, Franzel J. B.
    Van Guelpen, Bethany
    Vodicka, Pavel
    Wolk, Alicja
    Wu, Anna H.
    Peters, Ulrike
    Chan, Andrew T.
    Gunter, Marc J.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2022, 114 (05): : 740 - 752
  • [23] Circulating Immune Cell Count and Colorectal Cancer Risk: A Mendelian Randomization Study
    Constantinescu, Andrei-Emil
    Bull, Caroline J.
    Huyghe, Jeroen R.
    Gunter, Marc J.
    Murphy, Neil
    Timpson, Nicholas J.
    Vincent, Emma E.
    GENETIC EPIDEMIOLOGY, 2022, 46 (07) : 487 - 488
  • [24] Mendelian Randomization Study: The Association Between Metabolic Pathways and Colorectal Cancer Risk
    Jung, Su Yon
    Papp, Jeanette C.
    Sobel, Eric M.
    Zhang, Zuo-Feng
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [25] Mendelian randomization study: The association between metabolic pathways and colorectal cancer risk
    Jung, Su Yon
    Papp, Jeanette
    Sobel, Eric
    Zhang, Zuo-Feng
    CANCER RESEARCH, 2020, 80 (16)
  • [26] Dehydroepiandrosterone Sulfate and Colorectal Cancer Risk: A Mendelian Randomization Analysis
    Jayarathna, Dulari K.
    Renteria, Miguel E.
    Kho, Pik Fang
    Batra, Jyotsna
    Gandhi, Neha S.
    TWIN RESEARCH AND HUMAN GENETICS, 2022, 25 (4-5) : 180 - 186
  • [27] Diabetes and cancer risk: A Mendelian randomization study
    Goto, Atsushi
    Yamaji, Taiki
    Sawada, Norie
    Momozawa, Yukihide
    Kamatani, Yoichiro
    Kubo, Michiaki
    Shimazu, Taichi
    Inoue, Manami
    Noda, Mitsuhiko
    Tsugane, Shoichiro
    Iwasaki, Motoki
    INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (03) : 712 - 719
  • [28] Cathepsins and cancer risk: a Mendelian randomization study
    Deng, Tingting
    Lu, Xixue
    Jia, Xuemin
    Du, Jinxin
    Wang, Lijuan
    Cao, Baorui
    Yang, Meina
    Yin, Ying
    Liu, Fanjie
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [29] Genetically predicted thyroid function and risk of colorectal cancer: a bidirectional Mendelian randomization study
    Du, Qiang
    Zheng, Zhaoyang
    Wang, Yong
    Yang, Lie
    Zhou, Zongguang
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (15) : 14015 - 14024
  • [30] Genetically predicted thyroid function and risk of colorectal cancer: a bidirectional Mendelian randomization study
    Qiang Du
    Zhaoyang Zheng
    Yong Wang
    Lie Yang
    Zongguang Zhou
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 14015 - 14024